NCT05441943

Brief Summary

The primary aim of this study is to investigate and test whether the use of combined indocyanine green (ICG) lymphography and ultra high frequency ultrasonography can correctly identify lymphatic vessels and venoles in close proximity to each other, for identification prior to lymphovenous anastomosis (LVA) surgery.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
May 2022Dec 2026

Study Start

First participant enrolled

May 11, 2022

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

June 7, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

July 1, 2022

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

4.6 years

First QC Date

June 7, 2022

Last Update Submit

March 4, 2024

Conditions

Keywords

LymphedemaBreast CancerPostmastectomy LymphedemaLymphoedemaBreast Cancer LymphedemaAnastomoseLymphovenous anastomosisLVASurgeryBreast Neoplasm

Outcome Measures

Primary Outcomes (2)

  • Number of vessels planned for surgery surgery

    The number of mapped lymphatics vessels and venoles.

    Preoperative

  • Number of vessels found during surgery

    The number of vessels found during surgery. This number will be compared to the number of vessels planned for surgery.

    Perioprative

Secondary Outcomes (11)

  • Changes of arm volume

    Baseline and 3 months follow-up

  • Change of extracellular fluid (liters) relative to total body water (liters), measured in percentage.

    Baseline and 3 months follow-up

  • Changes of intracellular fluid (liters) relative to total body water (liters), measured in percentage.

    Baseline and 3 months follow-up

  • Changes of total body water (liters) relative to weight (kg), measured in percentage.

    Baseline and 3 months follow-up

  • Changes of proteins and minerals (kg) relative to weight (kg), measured in percentage.

    Baseline and 3 months follow-up

  • +6 more secondary outcomes

Study Arms (1)

Lymphovenous anastomosis surgery

EXPERIMENTAL

Lymphovenous anastomosis surgery with pre-operative planning using ICG lymphography and ultra high frequency ultrasound.

Procedure: Lymphovenous anastomosis

Interventions

Pre-operative planning prior to lymphovenous anastomosis using ICG lymphography and ultra high frequency ultrasound for mapping of applicable vessels. During surgery, mapped vessels are freely dissected and anastomosed.

Also known as: LVA, Lymphaticovenous anastomosis, Lymphaticovenular anastomosis
Lymphovenous anastomosis surgery

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • Iatrogenic lymphedema following treatment for breast cancer in upper extremity
  • Possible to obtain informed consent
  • Age\>18

You may not qualify if:

  • Duration of disease over 24 months
  • Smoker
  • Untreated or uncontrolled primary cancer
  • No applicable lymphatic vessels identified, using ICG lymphangiography
  • No applicable venous vessels identified using ultra high frequency ultrasound

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Plastic Surgery, Odense University Hospital

Odense, Region Syddanmark, 5000, Denmark

Location

Related Publications (32)

  • Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, Hunt KK, Mittendorf EA, Byrd DR, Julian TB, Boughey JC. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy. Support Care Cancer. 2019 Feb;27(2):495-503. doi: 10.1007/s00520-018-4334-7. Epub 2018 Jul 6.

    PMID: 29980907BACKGROUND
  • DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013 May;14(6):500-15. doi: 10.1016/S1470-2045(13)70076-7. Epub 2013 Mar 27.

    PMID: 23540561BACKGROUND
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.

    PMID: 33538338BACKGROUND
  • Maajani K, Jalali A, Alipour S, Khodadost M, Tohidinik HR, Yazdani K. The Global and Regional Survival Rate of Women With Breast Cancer: A Systematic Review and Meta-analysis. Clin Breast Cancer. 2019 Jun;19(3):165-177. doi: 10.1016/j.clbc.2019.01.006. Epub 2019 Jan 29.

    PMID: 30952546BACKGROUND
  • Markkula SP, Leung N, Allen VB, Furniss D. Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment. Cochrane Database Syst Rev. 2019 Feb 19;2(2):CD011433. doi: 10.1002/14651858.CD011433.pub2.

    PMID: 30779124BACKGROUND
  • Drobot A, Bez M, Abu Shakra I, Merei F, Khatib K, Bickel A, Ganam S, Bogouslavski G, Karra N, Mahran B, Kassis W, Kogan L, Drobot D, Weiss M, Koshima I, Kakiashvili E. Microsurgery for management of primary and secondary lymphedema. J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):226-233.e1. doi: 10.1016/j.jvsv.2020.04.025. Epub 2020 May 21.

    PMID: 32446874BACKGROUND
  • Seki Y, Kajikawa A, Yamamoto T, Takeuchi T, Terashima T, Kurogi N. The dynamic-lymphaticovenular anastomosis method for breast cancer treatment-related lymphedema: Creation of functional lymphaticovenular anastomoses with use of preoperative dynamic ultrasonography. J Plast Reconstr Aesthet Surg. 2019 Jan;72(1):62-70. doi: 10.1016/j.bjps.2018.09.005. Epub 2018 Sep 20.

    PMID: 30292697BACKGROUND
  • Brahma B, Putri RI, Reuwpassa JO, Tuti Y, Alifian MF, Sofyan RF, Iskandar I, Yamamoto T. Lymphaticovenular Anastomosis in Breast Cancer Treatment-Related Lymphedema: A Short-Term Clinicopathological Analysis from Indonesia. J Reconstr Microsurg. 2021 Oct;37(8):643-654. doi: 10.1055/s-0041-1723940. Epub 2021 Mar 1.

    PMID: 33648010BACKGROUND
  • Wolfs JAGN, de Joode LGEH, van der Hulst RRWJ, Qiu SS. Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up. Breast Cancer Res Treat. 2020 Jan;179(1):131-138. doi: 10.1007/s10549-019-05450-2. Epub 2019 Sep 21.

    PMID: 31542874BACKGROUND
  • Jorgensen MG, Toyserkani NM, Hansen FG, Bygum A, Sorensen JA. The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment. NPJ Breast Cancer. 2021 Jun 1;7(1):70. doi: 10.1038/s41523-021-00276-y.

    PMID: 34075045BACKGROUND
  • Kibar S, Dalyan Aras M, Unsal Delialioglu S. The risk factors and prevalence of upper extremity impairments and an analysis of effects of lymphoedema and other impairments on the quality of life of breast cancer patients. Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12433. Epub 2016 Jan 13.

    PMID: 26764197BACKGROUND
  • Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol. 2008 Dec 10;26(35):5689-96. doi: 10.1200/JCO.2008.16.4731. Epub 2008 Nov 10.

    PMID: 19001331BACKGROUND
  • Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018 Aug;7(4):379-403. doi: 10.21037/gs.2017.11.04.

    PMID: 30175055BACKGROUND
  • Chang EI, Skoracki RJ, Chang DW. Lymphovenous Anastomosis Bypass Surgery. Semin Plast Surg. 2018 Feb;32(1):22-27. doi: 10.1055/s-0038-1636510. Epub 2018 Apr 9.

    PMID: 29636650BACKGROUND
  • Mihara M, Hara H, Araki J, Kikuchi K, Narushima M, Yamamoto T, Iida T, Yoshimatsu H, Murai N, Mitsui K, Okitsu T, Koshima I. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PLoS One. 2012;7(6):e38182. doi: 10.1371/journal.pone.0038182. Epub 2012 Jun 4.

    PMID: 22675520BACKGROUND
  • Hayashi A, Giacalone G, Yamamoto T, Belva F, Visconti G, Hayashi N, Handa M, Yoshimatsu H, Salgarello M. Ultra High-frequency Ultrasonographic Imaging with 70 MHz Scanner for Visualization of the Lymphatic Vessels. Plast Reconstr Surg Glob Open. 2019 Jan 22;7(1):e2086. doi: 10.1097/GOX.0000000000002086. eCollection 2019 Jan.

    PMID: 30859043BACKGROUND
  • Visconti G, Bianchi A, Hayashi A, Salgarello M. Ultra-high frequency ultrasound preoperative planning of the rerouting method for lymphaticovenular anastomosis in incisions devoid of vein. Microsurgery. 2020 Sep;40(6):717-718. doi: 10.1002/micr.30600. Epub 2020 May 5. No abstract available.

    PMID: 32369213BACKGROUND
  • Hayashi A, Visconti G, Giacalone G, Hayashi N, Yoshimatsu H. Recent Advances in Ultrasound Technology: Ultra-High Frequency Ultrasound for Reconstructive Supermicrosurgery. J Reconstr Microsurg. 2022 Mar;38(3):193-199. doi: 10.1055/s-0041-1740129. Epub 2021 Dec 17.

    PMID: 34921372BACKGROUND
  • Jorgensen MG, Toyserkani NM, Hansen FCG, Thomsen JB, Sorensen JA. Prospective Validation of Indocyanine Green Lymphangiography Staging of Breast Cancer-Related Lymphedema. Cancers (Basel). 2021 Mar 26;13(7):1540. doi: 10.3390/cancers13071540.

    PMID: 33810570BACKGROUND
  • Jorgensen MG, Hermann AP, Madsen AR, Christensen S, Sorensen JA. Indocyanine green lymphangiography is superior to clinical staging in breast cancer-related lymphedema. Sci Rep. 2021 Oct 26;11(1):21103. doi: 10.1038/s41598-021-00396-2.

    PMID: 34702877BACKGROUND
  • Gupta N, Verhey EM, Torres-Guzman RA, Avila FR, Jorge Forte A, Rebecca AM, Teven CM. Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review. Plast Reconstr Surg Glob Open. 2021 Aug 25;9(8):e3770. doi: 10.1097/GOX.0000000000003770. eCollection 2021 Aug.

    PMID: 34476159BACKGROUND
  • Visconti G, Hayashi A, Tartaglione G, Yamamoto T, Bianchi A, Salgarello M. Preoperative planning of lymphaticovenular anastomosis in patients with iodine allergy: A multicentric experience. J Plast Reconstr Aesthet Surg. 2020 Apr;73(4):783-808. doi: 10.1016/j.bjps.2019.11.020. Epub 2019 Nov 29. No abstract available.

    PMID: 31813793BACKGROUND
  • Gallagher KK, Lopez M, Iles K, Kugar M. Surgical Approach to Lymphedema Reduction. Curr Oncol Rep. 2020 Jul 28;22(10):97. doi: 10.1007/s11912-020-00961-4.

    PMID: 32720071BACKGROUND
  • Ogata F, Narushima M, Mihara M, Azuma R, Morimoto Y, Koshima I. Intraoperative lymphography using indocyanine green dye for near-infrared fluorescence labeling in lymphedema. Ann Plast Surg. 2007 Aug;59(2):180-4. doi: 10.1097/01.sap.0000253341.70866.54.

    PMID: 17667413BACKGROUND
  • Klassen AF, Tsangaris E, Kaur MN, Poulsen L, Beelen LM, Jacobsen AL, Jorgensen MG, Sorensen JA, Vasilic D, Dayan J, Mehrara B, Pusic AL. Development and Psychometric Validation of a Patient-Reported Outcome Measure for Arm Lymphedema: The LYMPH-Q Upper Extremity Module. Ann Surg Oncol. 2021 Sep;28(9):5166-5182. doi: 10.1245/s10434-021-09887-y. Epub 2021 Jul 5.

    PMID: 34224044BACKGROUND
  • Coroneos CJ, Wong FC, DeSnyder SM, Shaitelman SF, Schaverien MV. Correlation of L-Dex Bioimpedance Spectroscopy with Limb Volume and Lymphatic Function in Lymphedema. Lymphat Res Biol. 2019 Jun;17(3):301-307. doi: 10.1089/lrb.2018.0028. Epub 2018 Nov 2.

    PMID: 30388062BACKGROUND
  • Mastick J, Smoot BJ, Paul SM, Kober KM, Hamolsky D, Madden LK, Conley YP, Dixit N, Hammer MJ, Fu MR, Miaskowski C. A Comparison of Supine Versus Stand-on Bioimpedance Devices to Assess Breast Cancer-Related Lymphedema. Lymphat Res Biol. 2021 Dec;19(6):553-561. doi: 10.1089/lrb.2020.0058. Epub 2021 Feb 9.

    PMID: 33567232BACKGROUND
  • Tang NSJ, Ramakrishnan A, Shayan R. Quality-of-life outcomes after operative management of primary and secondary lymphoedema: a systematic review. ANZ J Surg. 2021 Dec;91(12):2624-2636. doi: 10.1111/ans.16764. Epub 2021 Apr 6.

    PMID: 33825306BACKGROUND
  • Karafa M, Karafova A, Szuba A. The effect of different compression pressure in therapy of secondary upper extremity lymphedema in women after breast cancer surgery. Lymphology. 2018;51(1):28-37.

    PMID: 30248729BACKGROUND
  • Gasteratos K, Morsi-Yeroyannis A, Vlachopoulos NC, Spyropoulou GA, Del Corral G, Chaiyasate K. Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes. Breast Cancer. 2021 Sep;28(5):1002-1015. doi: 10.1007/s12282-021-01274-5. Epub 2021 Jul 12.

    PMID: 34254232BACKGROUND
  • Carl HM, Walia G, Bello R, Clarke-Pearson E, Hassanein AH, Cho B, Pedreira R, Sacks JM. Systematic Review of the Surgical Treatment of Extremity Lymphedema. J Reconstr Microsurg. 2017 Jul;33(6):412-425. doi: 10.1055/s-0037-1599100. Epub 2017 Feb 24.

    PMID: 28235214BACKGROUND
  • Fu MR, Cleland CM, Guth AA, Kayal M, Haber J, Cartwright F, Kleinman R, Kang Y, Scagliola J, Axelrod D. L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology. 2013 Jun;46(2):85-96.

Related Links

MeSH Terms

Conditions

Breast Cancer LymphedemaLymphedemaBreast NeoplasmsNeoplasmsBreast DiseasesLymphatic DiseasesSkin DiseasesPostoperative ComplicationsPathologic Processes

Condition Hierarchy (Ancestors)

Hemic and Lymphatic DiseasesPathological Conditions, Signs and SymptomsNeoplasms by SiteSkin and Connective Tissue Diseases

Study Officials

  • Caroline Lilja, MD

    Department of Plastic Surgery at Odense University Hospital

    PRINCIPAL INVESTIGATOR
  • Jens Ahm Sørensen, MD, Prof, PhD

    Department of Plastic Surgery at Odense University Hospital

    STUDY CHAIR
  • Jørn Bo Thomsen, MD, Prof, PhD

    Department of Plastic Surgery at Odense University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 7, 2022

First Posted

July 1, 2022

Study Start

May 11, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 5, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations